title: Complications of transcatheter aortic valve implantation: avoidance and management.
abstract: Transcatheter aortic valve implantation (TAVI) has taken the world of cardiovascular therapies by storm. The possibility of implanting aortic valves without recourse to sternotomy or cardiopulmonary bypass has been embraced by cardiologists, surgeons and patients alike as a revolution in management. First performed in 2002 by Alain Cribier, the technique has exploded into common use during the last three years, such that over 20,000 implants have now been undertaken worldwide. This article discusses complications of TAVI, their avoidance and management.
authors.affiliation: Sussex Cardiac Centre, Brighton, United Kingdom. david.hildick-smith@bsuh.nhs.uk
authors.forename: David
authors.initials: D
authors.lastname: Hildick-Smith
authors.forename: Simon
authors.initials: S
authors.lastname: Redwood
authors.forename: Michael
authors.initials: M
authors.lastname: Mullen
authors.forename: Martyn
authors.initials: M
authors.lastname: Thomas
authors.forename: Jan
authors.initials: J
authors.lastname: Kovac
authors.forename: Stephen
authors.initials: S
authors.lastname: Brecker
authors.forename: Uday
authors.initials: U
authors.lastname: Trivedi
authors.forename: Chris
authors.initials: C
authors.lastname: Young
authors.forename: Nevil
authors.initials: N
authors.lastname: Hutchinson
authors.forename: Phil
authors.initials: P
authors.lastname: Maccarthy
authors.forename: Bernard
authors.initials: B
authors.lastname: Prendergast
authors.forename: Mark
authors.initials: M
authors.lastname: De Belder
authors.forename: Mark
authors.initials: M
authors.lastname: Monaghan
authors.forename: Dan
authors.initials: D
authors.lastname: Blackman
authors.forename: Andreas
authors.initials: A
authors.lastname: Baumbach
authors.forename: Ganesh
authors.initials: G
authors.lastname: Manoharan
authors.forename: Neil
authors.initials: N
authors.lastname: Moat
mesh_terms: D001024:Aortic Valve Stenosis / Q000628:therapy*; D006328:Cardiac Catheterization / Q000009:adverse effects* / Q000295:instrumentation; D006350:Heart Valve Prosthesis; D019918:Heart Valve Prosthesis Implantation / Q000009:adverse effects* / Q000295:instrumentation / Q000379:methods; D006801:Humans; D018579:Patient Selection; D018570:Risk Assessment; D012307:Risk Factors; D016896:Treatment Outcome